Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_assertion type Assertion NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_head.
- NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_assertion description "[The preclinical mutation carrier group 2 scored significantly higher than the nonmutation carrier group for 3 of the SCL-90-R symptom dimensions (anxiety, paranoid ideation, and psychoticism).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_provenance.
- NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_assertion evidence source_evidence_literature NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_provenance.
- NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_assertion SIO_000772 17210818 NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_provenance.
- NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_assertion wasDerivedFrom befree-20140225 NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_provenance.
- NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_assertion wasGeneratedBy ECO_0000203 NP692156.RAvYyQHc8EsEeVyd53Ny4J6eDL8XIPfzdCTt3V6kAjCRQ130_provenance.